CSF2 and COVID-19: To test whether GM-CSF and IL-17A correlate with the severity of COVID-19, we first measured these two cytokines in the serum of patients with COVID-19 and of healthy blood donors and observed increased GM-CSF concentration in the patients (Fig. 5A).